Multiple Myeloma Research Consortium Shares its Insights into Effective and Efficient Biospecimen Management
News Jun 18, 2007
LabVantage has announced a webcast featuring the Multiple Myeloma Research Consortium (MMRC). The MMRC shares its insights into the implementation of LabVantage’s Sapphire BioBanking Solution for the effective and efficient biospecimen management system to support myeloma research throughout MMRC's partner network.
In the world of research, accurate, compliant and efficient management of biospecimens is critical. These specimens serve as the basis for research and development of tomorrow's drugs and medical treatments.
The MMRC reviews the challenges of sample collection, storage, management, and reporting associated with its myeloma specimens. It also addresses the specific barriers to specimen management and data warehousing faced by the MMRC, including how to: span the life cycle of the specimen, address the needs of multiple end users, capture correlating clinical data, maintain flexibility, and provide global visibility.
This webcast and further information about LabVantage's Sapphire BioBanking Solution are available at http://www.labvantage.com/products/biobanking/index.html.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE